Assunta De Rienzo

ORCID: 0000-0003-4397-9805
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Occupational and environmental lung diseases
  • Medical Imaging and Pathology Studies
  • Cancer Research and Treatments
  • Cancer Genomics and Diagnostics
  • Pleural and Pulmonary Diseases
  • Epigenetics and DNA Methylation
  • Genetic factors in colorectal cancer
  • Tissue Engineering and Regenerative Medicine
  • RNA modifications and cancer
  • Cancer-related Molecular Pathways
  • Cancer Cells and Metastasis
  • Graphene and Nanomaterials Applications
  • Pancreatic and Hepatic Oncology Research
  • Ferroptosis and cancer prognosis
  • Metastasis and carcinoma case studies
  • Immune Cell Function and Interaction
  • Neuroblastoma Research and Treatments
  • Single-cell and spatial transcriptomics
  • Lung Cancer Treatments and Mutations
  • RNA Research and Splicing
  • PI3K/AKT/mTOR signaling in cancer
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Cancer-related molecular mechanisms research
  • Radiomics and Machine Learning in Medical Imaging
  • Immune cells in cancer

Brigham and Women's Hospital
2015-2024

Harvard University
2013-2024

Dana-Farber Brigham Cancer Center
2013

Dana-Farber Cancer Institute
2013

Virginia Tech
2010-2013

Massachusetts General Hospital
2010-2013

Center for Cancer Research
2011

Medicina
2011

National Cancer Institute
2011

Mesothelioma Applied Research Foundation
2008

Julija Hmeljak Francisco Sánchez-Vega Katherine A. Hoadley Juliann Shih Chip Stewart and 95 more David I. Heiman Patrick Tarpey Ludmila Danilova Esther Drill Ewan A. Gibb Reanne Bowlby Rupa S. Kanchi Hatice U. Osmanbeyoglu Yoshitaka Sekido Jumpei Takeshita Yulia Newton Kiley Graim Manaswi Gupta Carl M. Gay Lixia Diao David L. Gibbs Vésteinn Thórsson Lisa Iype Havish S. Kantheti David T. Severson Gloria Ravegnini Patrice Desmeules Achim A. Jungbluth William D. Travis Sanja Đačić Lucian R. Chirieac Françoise Galateau-Sallé Junya Fujimoto Aliya N. Husain Henrique C.S. Silveira Valerie W. Rusch Robert C. Rintoul Harvey I. Pass Hedy L. Kindler Marjorie G. Zauderer David J. Kwiatkowski Raphael Bueno Anne S. Tsao Jenette Creaney Tara M. Lichtenberg Kristen Leraas Jay Bowen Ina Felau Jean C. Zenklusen Rehan Akbani Andrew D. Cherniack Kai Ye Michael S. Noble Jonathan A. Fletcher A. Gordon Robertson Ronglai Shen Hiroyuki Aburatani B. W. Robinson Peter J. Campbell Marc Ladanyi Hiroyuki Aburatani Rehan Akbani Adrian Ally Pavana Anur Joshua Armenia J. Todd Auman Miruna Balasundaram Saianand Balu Stephen B. Baylin Michael J. Becich Carmen Behrens Rameen Beroukhim Craig M. Bielski Tom Bodenheimer Arnoud Boot Jay Bowen Reanne Bowlby Denise Brooks Raphael Bueno Kai Ye Flavio Mavignier Cárcano Rebecca Carlsen André Lopes Carvalho Andrew D. Cherniack Dorothy Cheung Lucian R. Chirieac Juok Cho Eric Chuah Sudha Chudamani Carrie Cibulskis Leslie Cope Daniel Crain Jenette Creaney Erin Curley Sanja Đačić Ludmila Danilova Assunta De Rienzo Timothy Defreitas John A. Demchok Noreen Dhalla

Abstract Malignant pleural mesothelioma (MPM) is a highly lethal cancer of the lining chest cavity. To expand our understanding MPM, we conducted comprehensive integrated genomic study, including most detailed analysis BAP1 alterations to date. We identified histology-independent molecular prognostic subsets, and defined novel subtype with TP53 SETDB1 mutations extensive loss heterozygosity. also report strong expression immune-checkpoint gene VISTA in epithelioid strikingly higher than...

10.1158/2159-8290.cd-18-0804 article EN Cancer Discovery 2018-10-15

Background —Left ventricular hypertrophy (LVH) represents both an adaptive response to increased cardiac work load and a precursor state of heart failure. Recent evidence linked myocyte death by apoptosis with LVH It remained unclear, however, whether participated in the transition from left dysfunction (LVD). Methods Results —Cardiac apoptotic events changes apoptosis-specific genes were studied rat model chronic pressure overload induced transverse aortic constriction. The geometry...

10.1161/01.cir.99.23.3071 article EN Circulation 1999-06-15

Cancers arise by the gradual accumulation of mutations in multiple genes. We now use shotgun pyrosequencing to characterize RNA and expression levels unique malignant pleural mesotheliomas (MPMs) not present control tissues. On average, 266 Mb cDNA were sequenced from each four MPMs, a pulmonary adenocarcinoma (ADCA), normal lung tissue. Previously observed differences MPM confirmed. Point identified using criteria that require presence mutation at least reads both strands absence sequence...

10.1073/pnas.0712399105 article EN Proceedings of the National Academy of Sciences 2008-02-27

Activation of the stimulator interferon genes (STING) pathway promotes antitumor immunity but STING agonists have yet to achieve clinical success. Increased understanding mechanism action in human tumors is key developing therapeutic combinations that activate effective innate immunity. Here, we report malignant pleural mesothelioma cells robustly express and are responsive agonist treatment ex vivo. Using dynamic single-cell RNA sequencing explants treated with a agonist, observed CXCR3...

10.1158/2326-6066.cir-22-0017 article EN Cancer Immunology Research 2022-06-02

Activation of AKT/protein kinase B promotes a variety biological activities important in tumorigenesis, such as cell survival and cycle progression. We previously demonstrated amplification overexpression the AKT2 gene subset human pancreatic carcinomas. In this investigation, we assessed catalytic activity 50 frozen tissues (37 carcinomas, four benign tumors nine normal pancreata) by vitro assay. Twelve 37 (32%) carcinomas showed markedly elevated levels compared to pancreata begin tumors....

10.1002/jcb.10287 article EN Journal of Cellular Biochemistry 2002-01-01

Abstract Malignant mesothelioma has been linked to asbestos exposure and generally a poor prognosis because it is often diagnosed in advanced stages refractory conventional therapy. Human malignant mesotheliomas accumulate multiple somatic genetic alterations, including inactivation of the NF2 CDKN2A/ARF tumor suppressor genes. To better understand significance identify gene alterations that cooperate with loss function pathogenesis, we treated Nf2 (+/−) knockout mice induce mesotheliomas....

10.1158/0008-5472.can-05-2312 article EN Cancer Research 2005-09-15

Polycomb group (PcG) proteins are critical epigenetic mediators of stem cell pluripotency, which have been implicated in the pathogenesis human cancers. This study was undertaken to examine frequency and clinical relevance PcG protein expression malignant pleural mesotheliomas (MPM).Microarray, quantitative reverse transcriptase PCR (qRT-PCR), immunoblot, immunohistochemistry techniques were used cultured MPM, mesothelioma specimens, normal mesothelial cells. Lentiviral short hairpin RNA...

10.1158/1078-0432.ccr-11-0962 article EN Clinical Cancer Research 2011-10-26

Abstract Activation of the phosphatidylinositol-3-kinase (PI3K)/AKT survival pathway is a mechanism cytotoxic drug resistance in ovarian cancer, and inhibitors this can sensitize to drugs. The HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG) depletes some proteins involved PI3K/AKT signaling, e.g., ERBB2, epidermal growth factor receptor (EGFR), phosphorylated AKT (p-AKT). 17-AAG paclitaxel were combined (at fixed 1:1 ratio their IC50) four cancer cell lines that differ...

10.1158/1535-7163.mct-05-0445 article EN Molecular Cancer Therapeutics 2006-05-01

The current paradigm for elucidating the molecular etiology of cancers relies on interrogation small numbers genes, which limits scope investigation. Emerging second-generation massively parallel DNA sequencing technologies have enabled more precise definition cancer genome a global scale. We examined human primary malignant pleural mesothelioma (MPM) tumor and matched normal tissue by using combination sequencing-by-synthesis pyrosequencing methodologies to 9.6X depth coverage. Read density...

10.1371/journal.pone.0010612 article EN cc-by PLoS ONE 2010-05-13

Abstract Malignant pleural mesothelioma (MPM) is an aggressive cancer that occurs more frequently in men, but associated with longer survival women. Insight into the advantage of female patients may advance molecular understanding MPM and identify therapeutic interventions will improve prognosis for all patients. In this study, we performed whole-genome sequencing tumor specimens from 10 matched control samples to potential driver mutations underlying MPM. We identified differences gender...

10.1158/0008-5472.can-15-0751 article EN Cancer Research 2015-11-11

Abstract BRCA1‐associated protein‐1 ( BAP1 ) expression is commonly lost in several tumors including malignant pleural mesothelioma (MPM). Presence or absence of immunohistochemical nuclear staining tumor cells currently used for differential diagnosis MPM. In this study, a large cohort 596 MPM with available clinical data was analyzed to examine associations pattern and molecular features that may reflect the impact mutation on biology. Cases were classified according cells. Exome...

10.1002/path.5551 article EN cc-by The Journal of Pathology 2020-09-18

Abstract Purpose: Specificity protein 1 (SP1) is an oncogenic transcription factor overexpressed in various human malignancies. This study sought to examine SP1 expression malignant pleural mesotheliomas (MPM) and ascertain the potential efficacy of targeting these neoplasms. Experimental Design: qRT-PCR, immunoblotting, immunohistochemical techniques were used evaluate cultured MPM cells specimens normal mesothelial cells/pleura. MTS, chemotaxis, soft agar, β-galactosidase, Apo-BrdUrd...

10.1158/1078-0432.ccr-14-3379 article EN Clinical Cancer Research 2015-10-13

Abstract Malignant pleural mesothelioma (MPM) is an aggressive cancer arising from the mesothelial cells of pleura. About 80% cases are linked to asbestos exposure, while remainder may be related prior chest radiation, genetic predisposition or spontaneous occurrence. We analyzed transcriptomes (n = 211), whole exomes 99), and targeted 103) 216 malignant tumors. Four distinct molecular subtypes, sarcomatoid (S), epithelioid (E), biphasic-E, biphasic-S were identified using RNA-seq data....

10.1158/1538-7445.am2016-lb-331 article EN Cancer Research 2016-07-15
Coming Soon ...